Patents for C12R 1 - Micro-organisms (92,025) |
---|
01/30/1991 | EP0410615A1 Antiparasitic agent |
01/30/1991 | EP0410604A1 Heteropolysaccharide 105-4 |
01/30/1991 | EP0410499A1 Process for producing alkyl-methyl ketones |
01/30/1991 | EP0410498A2 Mutant microbial alpha-amylases with increased thermal, acid and/or alkaline stability |
01/30/1991 | EP0410430A2 Process for the microbiological discontinual preparation of L-carnitine |
01/30/1991 | EP0410326A2 Genetic control of acetylation and pyruvylation of xanthan gum |
01/30/1991 | EP0410246A1 Erythropoietin(EPO)-peptides and antibodies against them |
01/30/1991 | EP0410228A1 The thermo-inducible expression of heterologous genes in bacillus subtilis and means and methods for its achievement |
01/30/1991 | EP0409963A1 Immunoassay for fast homoarginine-sensitive alkaline phosphatase (fhap) and antibody useful therewith |
01/30/1991 | EP0409923A1 EXPRESSION OF THE i(PLASMODIUM) CIRCUMSPOROZOITE PROTEIN IN INSECT CELLS |
01/30/1991 | EP0409901A1 Lak cell cytotoxin |
01/30/1991 | EP0409878A1 Subtilisin mutations |
01/30/1991 | EP0177531B1 Antibodies, manufacture and use |
01/30/1991 | CA2051124A1 Proteins with tnf activity |
01/29/1991 | WO1991002077A1 Efficient directional genetic cloning system |
01/29/1991 | US4988798 Method for recovering recombinant proteins |
01/29/1991 | US4988677 Macrolide antibiotic and its use as a medicinal agent |
01/29/1991 | US4988622 Recombinant plasmid DNA pVN 22 coding biosynthesis of human leukocyte interferon alpha-I1 and strain Pseudomonas sp. 31 (pVN 22) - producer of human leukocyte interferon alpha-I1 containing same |
01/29/1991 | US4988620 Cloning, fermentation, purification |
01/29/1991 | CA2022185A1 Separation of anti-metal chelate antibodies |
01/29/1991 | CA1279594C Microbiological method of producing ethylene |
01/29/1991 | CA1279591C High level production of bovine growth hormone |
01/29/1991 | CA1279590C Recombinant dna, microorganisms containing same and their use in the production of amylases |
01/28/1991 | CA2022135A1 The thermo-inducible expression of heterologous genes in bacillus subtilis and means and methods for its achievement |
01/28/1991 | CA2021641A1 Process for producing alkyl-methyl ketones |
01/28/1991 | CA2020106A1 Control of expression of heterologous genes from lac promotors |
01/27/1991 | WO1991001990A1 Chimeric anti-cea antibody |
01/26/1991 | WO1991001329A1 Polypeptide inhibitor of viral replication |
01/26/1991 | WO1991001145A1 Pokeweed antiviral protein - monoclonal antibody conjugates |
01/26/1991 | CA2063801A1 Polypeptide inhibitor of viral replication |
01/24/1991 | WO1991000920A2 Process for preparing a protein by a fungus transformed by multicopy integration of an expression vector |
01/24/1991 | WO1991000919A1 Promoters of colony stimulating factor activity |
01/24/1991 | WO1991000917A1 Method for producing novel polyester biopolymers |
01/24/1991 | WO1991000916A2 Receptors for fibroblast growth factors |
01/24/1991 | WO1991000913A1 Inducible expression vectors |
01/24/1991 | WO1991000860A1 Nitrogenous ambruticines, process for obtaining them and their use |
01/24/1991 | WO1990015877A3 Methods, compositions and devices for growing cells |
01/24/1991 | WO1990014426A3 Saf polypeptide, gene, promoter and use for expression in streptomyces |
01/24/1991 | CA2035861A1 Promoters of colony stimulating factor activity |
01/23/1991 | EP0409607A2 Antibody to human interleukin-6 receptor |
01/23/1991 | EP0409521A2 Improved enzymatic oxidation of ceph C to glutaryl-7-amino-cephalosporanic acid |
01/23/1991 | EP0409488A2 Method for producing a heat-gelable beta-1,3-glucan |
01/23/1991 | EP0409472A1 Bone morphogenetic protein |
01/23/1991 | EP0409314A1 Stable, single-phased solutions of water-in-oil microemulsions derived from crude oil and allied products and which contain microorganisms and/or parts thereof |
01/23/1991 | EP0409242A1 Monoclonal antibody against human CD4 peptide |
01/23/1991 | EP0409156A1 Fused yeast for foreign protein expression, methods of producing said yeast and methods of producing foreign proteins |
01/23/1991 | EP0409113A1 Human erythropoietin muteins, their production and their use |
01/23/1991 | EP0409091A1 Antagonists of GM-CSF derived from the carboxyl terminus |
01/23/1991 | EP0409053A1 Process for purifying annexins |
01/23/1991 | EP0409040A1 Antibodies to Promoters of colony stimulating factor activity |
01/23/1991 | EP0408933A2 A mutant of pseudomonas, a strain yzh, and a process for producing 851yzh nutrient solution by application of the strain |
01/23/1991 | EP0408859A2 Monoclonal antibodies to activated endothelial cells |
01/23/1991 | EP0408690A1 L-malic acid degrading yeast for wine making |
01/23/1991 | EP0408663A1 Peptides inhibitors of hiv induced cell fusions and syncytia formation |
01/23/1991 | EP0408661A1 Methods of generating desired amino-terminal residues in proteins |
01/23/1991 | EP0408649A1 Bone and cartilage inductive compositions |
01/23/1991 | EP0387276A4 Method to produce immunodiagnostic reagents |
01/23/1991 | EP0183780B1 Distinguishing subsets of human cells |
01/22/1991 | WO1991002050A1 Enhanced lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides |
01/22/1991 | WO1991002002A1 Recombinantly produced human membrane cofactor protein (mcp) |
01/22/1991 | WO1991001370A1 Protection of nk cell cytolytic activity in pbmc |
01/22/1991 | WO1991001369A1 Preparation of human adherent lymphokine-activated killer (a-lak) cells |
01/22/1991 | US4987078 Plasmid vectors for expression in Escherichia coli and/or Bacillus subtilis |
01/22/1991 | US4987076 Uricase and a method for the preparation thereof |
01/22/1991 | US4987074 Method for producing the HgiAI restriction endonuclease and methylase |
01/22/1991 | US4987072 Macrocyclic antibiotics |
01/22/1991 | US4987071 RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
01/22/1991 | US4987070 Use of a 97 amino acid leader sequence from the E. coli B-galactosidase gene for the production of hanp and hptc as fusion proteins |
01/22/1991 | US4987069 Code for beta-lactamase |
01/22/1991 | CA2064072A1 Preparation of human adherent lymphokine-activated killer (a-lak) cells |
01/22/1991 | CA2063813A1 Enhanced lak cell activation by treatment of human peripheral blood mononuclear cells with amino acid amides |
01/22/1991 | CA2063788A1 Protection of nk cell cytolytic activity in pbmc |
01/22/1991 | CA1279315C Stabilizing polysaccharide solutions for tertiary oil recovery at elevated temperature |
01/22/1991 | CA1279279C Process for producing ribonucleosides |
01/22/1991 | CA1279277C Treponema hyodysenteriae bacterin and process therefor |
01/22/1991 | CA1279276C Polypeptides and antibiotics characteristic of papillomavirus and use for the in vitro diagnostic, the prevention and/or the control of papillomavirus infections |
01/20/1991 | CA2020729A1 Bone morphogenetic protein |
01/19/1991 | CA2021369A1 Tumor necrosis factor (tnf) inhibitor and method for obtaining the same |
01/18/1991 | CA2021294A1 Method for producing a heat-gelable .beta.lucan |
01/16/1991 | EP0408461A1 Protein with urate oxidase activity, recombinant gene coding therefor, expression vector, micro-organisms and transformed cells |
01/16/1991 | EP0408444A2 Galactan extracted Klebsiella, process for its preparation and its use as a medicament |
01/16/1991 | EP0408336A2 Antitumor antibiotic BU-3285T |
01/16/1991 | EP0408295A2 Nucleic acid sequence amplification methods |
01/16/1991 | EP0408220A2 Mould control in forage |
01/16/1991 | EP0408178A1 Immobilized protein G variants and the use thereof |
01/16/1991 | EP0408146A2 Method for the purification of therapeutically active recombinant acidic fibroblast growth factor |
01/16/1991 | EP0407939A1 Antiviral antibiotic BU-3889V |
01/16/1991 | EP0407543A1 Mammalian gap-43 compositions and methods of use |
01/16/1991 | EP0407490A1 Production of human prourokinase |
01/16/1991 | EP0407462A1 Dna binding proteins including androgen receptor |
01/16/1991 | EP0407430A1 Therapeutic murine monoclonal antibody |
01/16/1991 | EP0118547B1 Method for the preparation of glucosyltransferase |
01/16/1991 | CN1011243B Regulatory site of expression for heterogenetic gene in yeast |
01/16/1991 | CA2021147A1 Process for preparing and purifying an anticoagulant |
01/15/1991 | WO1991001330A1 Antagonists of gm-csf derived from the carboxyl terminus |
01/15/1991 | US4985364 Preparation of cyclopropanecarboxylic acids |
01/15/1991 | US4985360 Novel bilirubin oxidase which has a substrate specifity to bilirubin, but not to biliverdin, catechol and hemin |
01/15/1991 | US4985357 Yeasts, fungi, protozoa |
01/15/1991 | US4985144 Purification of protein antigens |
01/15/1991 | CA2062975A1 Antagonists of gm-csf derived from the carboxyl terminus |